TDP-43 shapeshifts to encipher FTD severity

被引：3

作者：

Barbieri, Edward M. ^{[1
]}

Shorter, James ^{[1
]}

机构：

[1] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

NATURE NEUROSCIENCE | 2019年 / 22卷 / 01期

关键词：

RNA-BINDING PROTEINS;

D O I：

10.1038/s41593-018-0299-6

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

TDP-43 forms cytoplasmic aggregates in degenerating neurons of frontotemporal dementia (FTD) patients. Laferriere et al. now establish that TDP-43 assemblies from distinct FTD subtypes have different structures, neurotoxicities, and seeding activities, which correlate with FTD severity. Thus, distinct pathological TDP-43 assemblies akin to prion strains might underpin distinct FTD subtypes.

引用

页码：3 / 5

页数：3

共 50 条

[1] TDP-43 shapeshifts to encipher FTD severity
Edward M. Barbieri
James Shorter
Nature Neuroscience, 2019, 22 : 3 - 5
[2] TDP-43 in FTD and ALS
Neumann, M.
BRAIN PATHOLOGY, 2010, 20 : 7 - 7
[3] Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD
Copley, Katie
Smirnov, Ashleigh
Mayne, Leland
Wang, Yuanhang
Black, Ben E.
Shorter, James
BIOPHYSICAL JOURNAL, 2024, 123 (03) : 485A - 486A
[4] Developing RNA Therapeutics for TDP-43 Proteinopathy in ALS/FTD
Copley, Katie E.
Smirnov, Ashleigh
Shorter, James
FASEB JOURNAL, 2022, 36
[5] Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD
Fang, Mark Y.
Markmiller, Sebastian
Vu, Anthony Q.
Javaherian, Ashkan
Dowdle, William E.
Jolivet, Philippe
Bushway, Paul J.
Castello, Nicholas A.
Baral, Ashmita
Chan, Michelle Y.
Linsley, Jeremy W.
Linsley, Drew
Mercola, Mark
Finkbeiner, Steven
Lecuyer, Eric
Lewcock, Joseph W.
Yeo, Gene W.
NEURON, 2019, 103 (05) : 802 - +
[6] Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
Cao, Tianyu
Mallika, Aswathy
Sinha, Irika
Baghel, Meghraj
Irwin, Katie
Ling, Jonathan
Wong, Philip C.
MOLECULAR THERAPY, 2024, 32 (04) : 487 - 487
[7] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Hayes, Lindsey R.
Kalab, Petr
NEUROTHERAPEUTICS, 2022, 19 (04) : 1061 - 1084
[8] Characterization of brainstem TDP-43 distribution in FTD cases with ALS features
Scarioni, M.
Gami-Patel, P.
Timar, Y. S.
Rozemuller, A. J.
Hoozemans, J. J.
Aronica, E.
Raaphorst, J.
Pijnenburg, Y. A.
Dijkstra, A. A.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 436 - 436
[9] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Lindsey R. Hayes
Petr Kalab
Neurotherapeutics, 2022, 19 : 1061 - 1084
[10] Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Chatterjee, Madhurima
Ozdemir, Selcuk
Fritz, Christian
Mobius, Wiebke
Kleineidam, Luca
Mandelkow, Eckhard
Biernat, Jacek
Dogdu, Cem
Peters, Oliver
Cosma, Nicoleta Carmen
Wang, Xiao
Schneider, Luisa-Sophia
Priller, Josef
Spruth, Eike
Kuhn, Andrea A.
Krause, Patricia
Klockgether, Thomas
Vogt, Ina R.
Kimmich, Okka
Spottke, Annika
Hoffmann, Daniel C.
Fliessbach, Klaus
Miklitz, Carolin
McCormick, Cornelia
Weydt, Patrick
Falkenburger, Bjorn
Brandt, Moritz
Guenther, Rene
Dinter, Elisabeth
Wiltfang, Jens
Hansen, Niels
Bahr, Mathias
Zerr, Inga
Floel, Agnes
Nestor, Peter J.
Duzel, Emrah
Glanz, Wenzel
Incesoy, Enise
Burger, Katharina
Janowitz, Daniel
Perneczky, Robert
Rauchmann, Boris S.
Hopfner, Franziska
Wagemann, Olivia
Levin, Johannes
Teipel, Stefan
Kilimann, Ingo
Goerss, Doreen
Prudlo, Johannes
Gasser, Thomas
NATURE MEDICINE, 2024, 30 (06) : 1771 - +

← 1 2 3 4 5 →